Stay updated with breaking news from Elevate Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Casted, the first B2B marketing platform built around audio and video content, today launches a new category, Amplified Marketing, and...
/PRNewswire/ -- Casted, the first B2B marketing platform built around audio and video content, today launches a new category, Amplified Marketing, and...
Neurava, a startup located in West Lafayette, Indiana, announced Monday (Nov. 1) that it has received more than $650,000 in seed funding led by Elevate Ventures with participation from Purdue Foundry, First Leaf Capital, UCB Biopharma, iO Life Ventures and angel investors.
Neurava, a startup located in West Lafayette, Indiana, announced Monday (Nov. 1) that it has received more than $650,000 in seed funding led by Elevate Ventures with participation from Purdue Foundry, First Leaf Capital, UCB Biopharma, iO Life Ventures and angel investors.
Riding a growing interest in protein degradation, researchers at the Indiana University School of Medicine identified a small-molecule degrader for a cancer-promoting target called SUMO1, which was previously considered "undruggable." The compound inhibited tumor growth in mouse models of human breast, colon and lung cancers being developed by startup HB Therapeutics.